Pasithea Therapeutics Corp's total assets for Q2 2025 were $17.01M, an increase of 16.03% from the previous quarter. KTTA total liabilities were $1.83M for the fiscal quarter, a 8.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.